A new study from Michigan Medicine found that Black Americans experience significant health inequities when receiving treatment for hepatic encephalopathy, a cirrhosis-related disorder. Elliot Tapper, M.D, a hepatologist and associate professor of internal medicine, discusses the inspiration for the study and highlights key findings. The goal of the research was not only to improve care for patients with chronic liver disease but also to help provide more equitable access to life-saving therapies for all, regardless of the condition.
